Clinical trial reports

  • Which European Sites Anchor Phase II–III Melanoma Trials?
  • Which Sites Are Most Active in European Lymphoma Phase II and III Trials?
  • Which CROs Support Neurology Phase III Trials in Europe and Where Is Demand Highest?
  • How Fast Are CTIS Cardiology Phase I Reviews and What Drives Delay?
  • Which EU Sites Are Most Active in Phase II and III Inflammatory Bowel Disease Trials?
  • Which CROs and Outsourced Functions Support Dermatology Phase III Trials in Europe?
  • Which CROs support European psychiatry phase 2 & 3 trials, and when are they needed most?
  • Which EU Sites Lead Phase III Heart Failure Trials, and Where Is Capacity Concentrated?
  • How Long Are Phase III Infectious Disease CTIS Reviews and What Drives Delay?
  • Which CROs Are Most Active in European Myelodysplastic Syndrome Phase 2 & 3 Trials?
  • How Long Do CTIS Reviews Take, and What Factors Drive Delays, in European Phase III Oncology Trials?
  • Which Endpoints Are Measured Most Often in European Heart Failure Phase II & III Trials?